Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)

Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis) Publisher Pubmed

Tavakolpour S^{1, 2} ; Alesaeidi S²

Show Affiliations

1. Pharmaceutical Sciences Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2. Rheumatology and Internal Medicine, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: International Immunopharmacology Published:2019

Abstract

[No abstract available]

2. The Efficacy and Safety of Rituximab in Anca-Associated Vasculitis: A Systematic Review, Biology (2022)

3. Two Decades Rituximab Therapy in Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis, Current Drug Targets (2025)

4. Successful Treatment Strategies in Granulomatosis With Polyangiitis-Associated Peripheral Ulcerative Keratitis, Cornea (2016)

Experts (# of related papers)

View all Related Experts

Sasan Dabiri Satri (1)

Arash Jafarieh (1)

Style	Citing Format
MLA	Tavakolpour S, Alesaeidi S. "Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)." International Immunopharmacology, vol. 70, no. , 2019, pp. 67-68.
APA	Tavakolpour S, Alesaeidi S (2019). Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis). International Immunopharmacology, 70(), 67-68.
Chicago	Tavakolpour S, Alesaeidi S. "Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)." International Immunopharmacology 70, no. (2019): 67-68.
Harvard	Tavakolpour S, Alesaeidi S (2019) 'Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)', International Immunopharmacology, 70(), pp. 67-68.
Vancouver	Tavakolpour S, Alesaeidi S. Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis). International Immunopharmacology. 2019;70():67-68.
BibTex	@article{ author = {Tavakolpour S and Alesaeidi S}, title = {Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis)}, journal = {International Immunopharmacology}, volume = {70}, number = {}, pages = {67-68}, year = {2019} }
RIS	TY - JOUR AU - Tavakolpour S AU - Alesaeidi S TI - Rituximab As an Effective and Probably Safe Treatment for Granulomatosis With Polyangiitis (Wegener's Granulomatosis) JO - International Immunopharmacology VL - 70 IS - SP - 67 EP - 68 PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract